Financials
- Market Capitalization 294.19 M
- Employee 22
- Founded 2017
- CEO N/A
- Website www.q32bio.com
- Headquarter Delaware, United States
- FIGI BBG00CTTJWQ9
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
2.31
Relación precio/flujo de caja
63.04
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3046 | CBIO Crescent Biopharma, Inc. - Common Stock | 14.90 USD | -2.68% | -11.41% | -17.91% | +26.16% | 410.82 M USD | ||
| 3112 | UPB Upstream Bio, Inc. - Common Stock | 7.13 USD | -0.14% | -8.24% | +16.89% | -35.94% | 388.01 M USD | ||
| 3339 | AMRN Amarin Corporation plc - American Depositary Shares, each repre | 14.53 USD | +1.11% | -4.53% | -5.65% | -6.62% | 304.68 M USD | ||
| 3733 | OKUR OnKure Therapeutics, Inc. - Class A Common Stock | 4.22 USD | 0.00% | -6.64% | +0.24% | +72.24% | 170.47 M USD |